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ABSTRACT  
Background: Nutritional status (NS), though frequently affected in onco-geriatric patients, is no standard 
part of a geriatric assessment. The aim of this study was to analyse the association between a preoperatively 
impaired NS and geriatric domain impairments and adverse postoperative outcomes in onco-geriatric 
surgical patients. 
Methods: 309 patients ≥70 years undergoing surgery for solid tumours were prospectively recruited. Nine 
screening tools were preoperatively administered as part of a geriatric assessment. NS was based on BMI, 
weight loss and food intake. Odds ratio’s (OR) and 95% confidence intervals (95%CI) were estimated using 
logistic regression analysis. The occurrence of 30-day adverse postoperative outcomes was recorded.   
Results: At a median age of 76 years, 107 patients (34.6%) had an impaired NS. Decreased performance 
status and depression were associated with an impaired NS, when adjusted for tumour characteristics and 
comorbidities (ORPS>1 3.46; 95%CI 1.56-7.67. ORGDS>5 2.11; 95%CI 1.05-4.26). An impaired NS was an 
independent predictor for major complications (OR 3.3; 95%CI 1.6-6.8). Ten out of 11 patients who 
deceased had an impaired NS. 
Conclusion: An impaired NS is prevalent in onco-geriatric patients considered to be fit for surgery. It is 
associated with decreased performance status and depression. An impaired NS is a predictor for adverse 
postoperative outcomes. NS should be incorporated in a geriatric assessment. 
 
Keywords: Nutritional status; Geriatric assessment; Surgery; Postoperative complications; Oncology; Aged 
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INTRODUCTION 
Cancer is primarily a disease of the elderly. Currently, 50% of all malignancies are diagnosed in patients 65 
years and older and it is predicted this percentage will increase to 70% by 2030[1]. Surgery plays an 
essential role in the treatment of solid tumours and it is therefore expected that increasing numbers of onco-
geriatric patients will require surgery. Whilst fit onco-geriatric patients might recover from surgery as well 
as their younger counterparts, it is acknowledged that patients with geriatric domain impairments are at an 
increased risk of adverse postoperative outcomes, mortality and discharge to a non-home institution[2-5]. 
The preoperative identification of these impairments, utilizing screening elements of a Geriatric Assessment 
(GA), is essential in this heterogeneous population of onco-geriatric surgical patients.  
 
Though not frequently included in a GA[6], nutritional status (NS) is one of the geriatric domains that is 
frequently impaired in onco-geriatric patients[7-9]. Recent studies on middle-aged and elderly cancer 
patients, reported high numbers of patients at nutritional risk or being malnourished (32% to 64.2%)[7-9]. 
These studies were performed amongst cohorts in which the majority of patients was diagnosed with 
advanced disease (80.6% stage III/IV and 46.3% with metastases, respectively)[7,9] and frequently 
underwent chemotherapy with palliative intent (58.3%)[8]. Advanced disease is a known risk factor for 
malnutrition and many chemotherapeutic treatments are infamous for their side effects, such as nausea, 
vomiting and mucositis, increasing the risk for malnutrition even further[10,11]. However, in recent surgical 
onco-geriatric cohorts with fewer patients with advanced disease, the prevalence of an impaired NS or risk 
thereof was also as high as 34.1% and 48%, respectively[12,13].  
As nutritional impairment is rather a multifactorial than an isolated problem, improving the understanding of 
geriatric domain impairments associated with malnourishment could lead to timely preventive measures[14]. 
For that, the aim of this study was to analyse the association between preoperatively impaired NS, the 
impairments in other geriatric domains, and the occurrence of adverse postoperative outcomes in onco-
geriatric surgical patients. 
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MATHERIALS AND METHODS 
Design and cohort definition 
Data were derived from the preoperative risk estimation for onco-geriatric patients (PREOP) study, an 
international prospective cohort study. The PREOP-study was approved by the appropriate ethics 
committees and was registered at the Dutch Trial register (Trial ID: NTR1567) and United Kingdom register 
(Research Ethics Committee reference: 10/H1008/59). 
Data deriving from centres that included less than ten patients were excluded from analyses, to reduce the 
influence of selection bias. Of the 14 medical centres initially adhering to the project, eight were able to 
enrol ten or more patients in the present study. When peri- or postoperatively patients appeared to have a 
benign condition (n=19), they were excluded from further analyses as the association between cancer and 
NS is an important factor in the current analyses.  
The detailed cohort definition and study protocol were published previously[12,15]. In summary, patients 
aged 70 years and older, undergoing elective surgery for a solid tumour were included. Preoperatively, a 
battery of screening tools, assessing all domains recommended for a GA, was administered (Table 1).  
Screening tools that assessed multiple geriatric domains were excluded from analyses, as these will not 
provide an answer to the research question of the current study. Complications up to 30 days after surgery 
were registered using the Clavien-Dindo classification. Major complications were defined as grade three to 
grade five, which were complications requiring surgical, endoscopic or radiological intervention (grade 3); 
life threatening complications requiring intensive care management (grade 4); and death of a patient (grade 
5)[26].  
 
Nutritional status 
To determine the risk for an impaired NS, the nutritional risk screening (NRS) scale, based on the NRS-
2002, was used[24]. Patients were stratified according to the following criteria:  
• Normal NS 
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• Mildly impaired NS: weight loss greater than 5% in the previous three months or a food intake below 
50-75% of normal requirement in the preceding week;  
• Moderately impaired NS: weight loss greater than 5% in the previous two months or a body mass 
index (BMI) between 18.5 and 20.5 kg/m2 and impaired general condition or a food intake below 25-
50% of normal requirement in the preceding week; 
• Severely impaired NS: weight loss greater than 5% in the previous month or a weight loss greater 
than 15% in three months or a BMI less than 18.5 kg/m2 and an impaired general condition or a food 
intake below 25% of normal requirement in the preceding week.  
 
Statistical analysis 
Results on the geriatric screening tools and the occurrence of major postoperative complications were 
analysed as dichotomized values, based on predefined, literature based cut-off points. Categorical data were 
described as frequencies and proportions, and continuous variables as median and interquartile range (i.q.r.).  
For further analyses, NS was considered as a dependent variable. Logistic regression analysis was used to 
estimate odds ratio’s (OR) and 95% confidence intervals (95% CI), which were at least adjusted for centre. 
Both complete cohort analyses as well as a sub-group analyses for patients with intra-abdominal tumours 
were performed. Firstly, the associations between patients’ demographics and disease characteristics and NS 
(impaired versus normal) were estimated. Subsequently, the associations between the geriatric screening 
tools and NS were estimated in a model adjusted for centre (model 1) and in a model adjusted for 
statistically significant confounders (model 2 for the complete cohort or model 3 for patients with intra-
abdominal tumours). 
The association between an impaired NS and other geriatric domain impairments as independent variables 
and the occurrence of major postoperative complications as a dependent variable, was estimated using 
backwards stepwise logistic regression analysis, whilst forcing statistically significant patients’ and disease 
characteristics into the model[12]. The association between an impaired NS and 30-day mortality was 
evaluated using Fisher’s exact test.  
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Missing values for the geriatric screening tools were addressed by multiple imputation, as the missing values 
were supposed to be missing (completely) at random. Multiple imputation was performed for the total scores 
on the questionnaires and was based on available results on the screening tools, age, gender, living situation, 
preoperative haemoglobin level, type of tumour, tumour stage, type of surgery and number of 
comorbidities[12,27]. The reported results on the screening tools were pooled values, which were average 
values calculated from the five imputed datasets[12]. 
Missing values for tumour stage (n=32) were not addressed by multiple imputation, leading to multivariate 
logistic regression analyses of 277 cases for model 2. Sensitivity analyses were performed for model 1, to 
discover possible discrepancies between complete case analyses based on model 2 and analyses of the entire 
cohort.  
Data analysis and multiple imputation were performed using IBM SPSS Statistics 23. P-values ≤ 0.05 were 
considered statistically significant.   
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RESULTS 
Baseline characteristics 
Data of 309 patients deriving from eight medical centres were analysed. Baseline characteristics are shown 
in table 2. A total of 190 patients were female (61.5%) and the median age was 76 years (i.q.r.: 8). The vast 
majority of patients had an intra-abdominal tumour (n = 207; 67%). Patients were most frequently planned 
for colorectal and breast cancer surgery (n=117, 37.6% and n=77, 24.8%, respectively). The 9 tumour sites 
that were classified as remaining, were thyroid (n=5), anus (n=3) and prostate (n=1). The pathologists’ 
reports confirmed stage 1, 2, 3 and 4 disease in 76 (24.6%), 83 (26.9%), 65 (21%) and 53 (17.2%) patients, 
respectively.  
 
Nutritional status 
Table 3 shows the associations between the patients’ demographics and disease characteristics and NS. A 
total of 202 (65.4%) patients were defined as having a normal NS, 81 (26.2%) had a mild nutritional 
impairment and 26 (8.4 %) had a moderate or severe nutritional impairment. Advanced age was overall not 
statistically significantly associated with the risk for an impaired NS, except for the group aged 80 to 84 
years old (OR 2.2; 95% CI 1.1-4.5). A high number of comorbidities was associated with an impaired NS 
(OR 2.10; 95% CI 1.20-3.68). Patients with a tumour located in the pancreas, biliary tract, stomach, 
oesophagus, kidney, bladder, colon or rectum had the highest risks for an impaired NS. With increasing 
tumour stage, the risk for an impaired NS increased as well, whilst the 95% CI’s did overlap (Stage 3: OR 
2.1; 95% CI 1.1-3.9. Stage 4: OR 2.6; 95% CI 1.2-5.4). In a sub-group analysis on patients with intra-
abdominal tumours, a high number of comorbidities and a tumour located in the pancreas or biliary tract 
were associated with an impaired NS (ORComorbidities≥4 2.4; 95% CI 1.3-4.5. ORpancreas and biliary tract 3.1; 95% CI 
1.1-8.4 with reference to colorectal cancer).  
 
Geriatric domains associated with nutritional status 
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A total of 65.4% of the patients with an ECOG PS >1 had an impaired NS (Table 4). Furthermore, an 
impaired functional status or signs of depression were frequently accompanied by an impaired NS (51.9% of 
TUG>20, 50.7% of ADL>0 and 50.6% of GDS>5). The majority of patients that did not have a geriatric 
domain impairment, had a normal NS as well (ranging from 68.9% for TUG≤20 to 73.7% for IADL8). The 
domains significantly associated with an impaired NS were ECOG PS (ORPS>1 3.5; 95% CI 1.6-7.7) and 
GDS (ORGDS>5 2.1; 95% CI 1.1-4.3), when adjusted for centre, age, comorbidities, tumour site and tumour 
stage (Table 4, model 2). In a sub-group analysis on patients with intra-abdominal tumours ADL (ORADL>0 
2.2; 95% CI 1.1-4.6), IADL (OR<8 2.8; 95% CI 1.5-5.5), ECOG PS (ORECOG PS>1 3.4; 95% CI 1.4-8.0) and 
GDS (ORGDS>5 2.3; 95% CI 1.1-4.8) were significantly associated with an impaired NS, when adjusted for 
centre and comorbidities (Table 4, model 3). 
 
Nutritional status and adverse postoperative outcomes 
A total of 160 (51.8%) patients experienced at least one complication within 30 days after surgery. Major 
complications occurred in 57 (18.4%) patients, including death in 11 patients (30-day mortality rate: 3.6%). 
Of the 11 patients who deceased within 30 days postoperatively, ten patients had an impaired NS (90.9%) 
(p<0.001). Of all patients with a normal NS, 90.6% did not experience any major postoperative 
complications. Of all patients with an impaired NS, 35.5% experienced major postoperative complications. 
The best combination of screening tools with regard to predicting the risk for major postoperative 
complications comprised an assessment of NS, TUG and ASA score (table 5), as was previously shown[12]. 
We therefore reinforce the statement that the assessment of NS preoperatively, allows a clear understanding 
of the operative risk.  
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DISCUSSION 
Onco-geriatric patients undergoing elective surgery, can be considered a selected and thus relatively fit part 
of the onco-geriatric population[28]. Nevertheless, an impaired NS was frequently seen in this cohort of 
onco-geriatric surgical patients (34.6%). An impaired NS was associated with both tumour characteristics 
and an increased number of other comorbidities as well as decreased performance status, signs of depression 
and an impaired functional status. An impaired NS is an important predictor for major complications 
including death.  
 
The prevalence of an impaired NS is comparable with several other cohorts of onco-geriatric patients, whilst 
a lower prevalence was to be expected as fewer patients (38.2%) were diagnosed with advanced disease[7-
9]. This discrepancy between observed and expected values can be explained by either an underestimation 
of the prevalence of malnutrition in the other cohorts, an overestimation in the current study or by the fact 
that the other cohorts concern selected patients as well, i.e. with no or few geriatric domain impairments. 
Bozzetti et al. assessed NS using the NRS-2002, which is similar to the nutritional screening in the current 
study and has proven to be suitable for use in hospitalized patients and, specifically, in cancer patients[7,29]. 
The study by Aaldriks et al. administered the Mini Nutritional Assessment, which has been validated for 
elderly people, with a sensitivity of 96% and specificity of 98% in elderly patients (not specifically cancer 
patients), and was found to be able to detect a risk of malnutrition before changes in weight or albumin 
levels occurred[8,30]. Thus underestimation of the prevalence of malnutrition in the other studies or an 
overestimation in the current study are unlikely. 
 
It is likely that these cohorts of patients, undergoing active anti-cancer treatment or at least able to attend an 
ambulatory consultation, consist of selected and relatively fit patients as well. This hypothesis is 
substantiated by the higher prevalence of (risk of) malnutrition in another study of onco-geriatric patients by 
Paillaud et al. (64.2%)[9]. Participants of this study were patients that were referred to a geriatric oncology 
clinic, thus with a higher a priori chance of geriatric domain impairments. This was subsequently confirmed 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
12 
 
by, for example, a PS>1 in 50.4% of patients, compared to 16.8% in the current cohort and 20% in the cohort 
from Bozzetti et al., and a MMSE≤24 in 29.8%, compared to 9% in the cohort from Aaldriks et al. These 
results suggest that, maybe even stronger than disease characteristics, geriatric domain impairments are 
associated with NS. It should be emphasized that these prevalences of an impaired NS stem from cohorts in 
which a decision on treatment modality had already been made and thus, extrapolating results to all onco-
geriatric patients in daily clinical practice should occur with caution.  
 
The results of the current study show that in onco-geriatric patients, independent of tumour site and stage 
and comorbidities, impairments in the geriatric domains performance status, mood and functional status are 
associated with the risk of an impaired NS. The results maintained in a sub-group analysis on patients with 
intra-abdominal tumours, whom are at greatest risk for both an impaired NS[7,9] and adverse outcomes after 
major surgery[12]. The results are comparable to results found in different studies including onco-geriatric 
patients or elderly hospitalized patients[9,31-33]. Other associated geriatric domain impairments were 
cognitive and mobility impairments, which were assessed with the MMSE, TUG and risk of falls.  
 
The importance of preoperative nutritional screening is emphasized by the fact that out of all geriatric 
screening tools, an impaired NS – combined with TUG-score and ASA status – was best in predicting the 
occurrence of major postoperative complications. On top of that, ten out of 11 patients who deceased within 
30-days postoperatively, had an impaired NS. Similarly, in patients ≥65 years undergoing 
pancreaticoduodenectomy for benign disease, a ‘Severe Nutritional Risk’ was found to be a prognostic 
factor for long-term survival (adjusted hazard ratio 2.74; 95% CI 1.25-6.02)[34]. Furthermore, NS, assessed 
either by the MNA-score, recent weight loss, body mass index (BMI) or serum albumin levels, are known 
prognostic factors of survival and response to chemotherapy in cancer patients[5,8,35]. Data on the 
predictive ability of nutritional markers on postoperative outcomes in the elderly general surgery and hip 
surgery patient populations are scarce and nutritional markers are operationalized in several ways, according 
to a systematic review including 15 studies[36]. Serum albumin is a frequently investigated nutritional 
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parameter (13 out of 15 studies) with – overall – positive results regarding its predictive ability of 
postoperative outcomes such as postoperative complications, mortality and length of hospital stay. However, 
serum albumin might be merely a marker of inflammatory metabolism rather than a pure representative of 
nutritional status in surgical patients[36]. Three included studies used a nutritional questionnaire, such as the 
MNA or the food frequency questionnaire. These were not associated with adverse postoperative outcomes. 
Out of 15 studies, one was comparable to the current study: a retrospective study on elderly gastrointestinal 
surgery patients, which found ≥10% weight loss in 6 months as a risk factor for postoperative morbidity. 
Despite promising results regarding weight loss, BMI and serum albumin levels, based on the current 
literature it can be concluded, that no consensus has been reached as to what an appropriate nutritional 
screening tool entails and what its’ exact value is.  
 
The use of nutritional interventions in order to improve these outcomes has not been clearly established 
yet[35,37,38]. A meta-analysis on the influence of nutritional support on adverse outcomes in cancer 
patients, showed no advantage for the intervention arms[37]. It was noted that the lack of effect might be 
attributed to poor study designs and heterogeneous patient populations. However, colorectal cancer patients 
subjected to a so-called trimodal prehabilitation program, consisting of nutritional counselling, protein 
supplementation, anxiety reduction exercises and physical exercise, showed improved functional outcome 
after surgery[39]. Furthermore, over the last several years, multiple studies suggested that enhanced 
recovery programs for elderly surgical patients were feasible and led to equally positive results as compared 
to their younger counterparts[40-42]. Unfortunately, elderly patients have high variability within their own 
group and what was demonstrated for patients with colorectal cancer, was not repeated for elderly patients 
with gastric cancer[43]. These results endorse the importance of an integrated approach in cancer patients, 
assessing at least NS, performance status and mood. Furthermore, more than from a strict list of 
postoperative prescriptions within a protocol, selected elderly patients might benefit from controlled and 
tailored (p)rehabilitation programmes. 
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Due to the cross-sectional nature of the current analyses, no clear conclusions on possible causal relations 
regarding NS and impairments in other geriatric domains can be drawn. The association between an 
impaired NS, functional status and depression can go both ways and the influence of common risk factors, 
such as disease burden and social factors, cannot be ignored.  
 
It can be hypothesized that the link between impaired NS, depression, functional impairment and adverse 
postoperative outcomes, is via inflammatory pathways. It is known that aging is accompanied by a low-
grade inflammatory state and that increased levels of pro-inflammatory cytokines are associated with 
functional decline, multiple geriatric domain impairments, frailty and mortality in the elderly[44-46]. 
Furthermore, cancer patients, especially in an advanced stage, are at risk for cachexia. This is a complex and 
systemic syndrome characterized by loss of skeletal muscle mass (with or without loss of fat mass), often 
accompanied by reduced food intake and systemic inflammation and frequently leading to functional 
impairment[47]. Finally, bidirectional associations between diet and depression via inflammatory pathways, 
have been postulated. Diet can either promote or attenuate inflammatory effects, inflammation can induce 
‘sickness behaviour’ including depressive symptoms in susceptible persons and depression can increase pro-
inflammatory cytokine production[48,49]. On top of that, depressed patients elicit higher inflammatory 
responses to physical and psychological stress[49], thus putting them at increased risk for adverse outcomes 
after a major stressor such as surgery. Future research should point out whether these hypotheses can be 
confirmed in an onco-geriatric population, in which multiple parameters (e.g. aging, tumour biology and 
cancer treatment effects) influence the inflammatory state[50]. 
 
The main strength of our study is its comprehensive and detailed assessment of patients’ demographics, 
disease characteristics and geriatric domains in a cohort of onco-geriatric surgical patients, who were 
prospectively recruited in multiple centres from different countries. Previous studies have focused on 
impaired NS and its association with other geriatric domain impairments in cohorts including many non-
surgical patients with advanced disease and/or undergoing palliative treatment, whereas the current study 
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focused on patients that were considered fit for surgery and were, moreover, less frequently diagnosed with 
advanced disease. These results should raise awareness amongst surgeons on NS being a multifactorial and 
prevalent issue in their patient population.  
 
An impaired NS is frequently seen in onco-geriatric patients considered to be fit for surgery. The results of 
the current study confirm that an impaired NS is associated with functional impairments and possible 
depression in these patients. Moreover, our data substantiate that NS is an important risk factor for adverse 
postoperative outcomes. This emphasizes the importance of a geriatric assessment in onco-geriatric surgical 
patients and that a nutritional assessment should be an essential part of this. Identification of the patients 
with an impaired NS is of the utmost importance, especially as they might benefit from preventive 
strategies.  
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Table 1. Components of PREOP 
Test Acronym Purpose Cut-off value for 
adverse results 
Range of 
possible scores 
Timed Up and Go[16] a TUG a walking test to measure 
functional status 
>20 secondsb Not applicable 
Activities of Daily 
Living[17] 
ADL depicts dependency 
regarding bathing, dressing, 
toileting, transfer, continence 
and feeding 
>0 0 - 12 
Instrumental Activities 
of Daily Living[18] 
IADL a questionnaire regarding 8 
items needed to perform 
independently to maintain 
independence in the 
community 
<8 0 - 8 
Eastern Cooperative 
Oncology Group 
performance status[19] 
ECOG 
PS 
a physician’s perspective of 
a patient’s functional status; 
ranging from 0 to 4  
>1 0 - 4 
Mini Mental State 
Examination[20] 
MMSE a test consisting of 11 
questions to assess cognitive 
function 
≤26 0 - 30 
Geriatric Depression 
Scale[21] 
GDS a 15-item self-rating 
depression screening scale 
for elderly populations 
>5 0 - 15 
Brief Fatigue 
Inventory[22] 
BFI a 9-item questionnaire to 
report on fatigue severity in 
cancer patients 
>3 0 - 10 
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American Society for 
Anaesthesiologist 
scale[23]c 
ASA to quantify preoperative 
physical status and estimate 
anaesthetic risk 
≥3 1 - 5 
Nutritional Risk 
Screening[24] 
NS nutritional status based on 
recent weight loss, overall 
condition and reduction of 
food intake 
Impaired 
nutritional status 
was compared to 
normal nutritional 
status 
Normal to 
severely 
impaired 
nutritional 
status 
a
 Patients performed the TUG two times and for each patient, the mean of the two time measurements was 
calculated; b based on literature and the distribution of the mean values in the current study population, a 
score of less than or equal to 20 seconds on the TUG was considered a low score[25]; c the ASA-
classification was determined by an anaesthesiologist. 
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Table 2. Patients’ characteristics 
Variable Value 
Gender, female 190 (61.5) 
Age 
   70-74 
   75-79 
   80-84 
   ≥85 
 
110 (35.6) 
99 (32.0) 
69 (22.3) 
31 (10.0) 
Weight (kg)a  
   Female 
   Male 
 
67 (15.6) 
73 (14.6) 
BMI (kg/m2)a 
   Female 
   Male 
 
26 (5.8) 
25 (3.9) 
Living situation 
   Independent/family 
   Residential care/nursing home 
 
304 (99.3) 
2 (0.7) 
Comorbiditiesa 3 (2) 
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Cancer siteb 
   Superficial 
   Intra-abdominal 
 
   Breast 
   Colorectal 
   Gastric and oesophageal  
   Gynaecological 
   Pancreas and biliary tract 
   Remaining 
   Renal and bladder 
   Soft tissue and skin 
 
102 (33.0) 
207 (67.0) 
 
77 (24.8) 
117 (37.6) 
22 (7.1) 
18 (5.8) 
29 (9.3) 
9 (2.9) 
23 (7.4) 
16 (5.1) 
Tumour stage 
   Stage 1 
   Stage 2 
   Stage 3 
   Stage 4  
   Unclassified/missing 
 
76 (24.6) 
83 (26.9) 
65 (21.0) 
53 (17.2) 
32 (10.4) 
Values in parentheses are percentages unless indicated 
otherwise; a values are median (i.q.r.); b one patient was 
operated on colon and renal cancer and one on melanoma 
skin cancer and breast cancer: for tumour staging and 
subsequent analyses the most severe disease was analysed; 
kg = kilograms; BMI = Body Mass Index 
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Table 3. Association between patients’ characteristics and impaired nutritional status 
Variable Normal 
nutritional 
status 
Impaired 
nutritional 
status 
Adjusted  ORb, c Adjusted ORb, d 
Gender 
Female 129 (67.9) 61 (32.1) 1 1 
Male 73 (61.3 ) 46 (38.7) 1.14 (0.67-1.96) 0.74 (0.42-1.33) 
Age 
70-74 80 (72.7) 30 (27.3) 1 1 
75-79 64 (64.6) 35 (35.4) 1.27 (0.67-2.42) 1.48 (0.71-3.07) 
80-84 41 (59.4) 28 (40.6) 2.22 (1.10-4.48) 1.97 (0.88-4.41) 
≥85 18 (58.1) 13 (41.9) 2.29 (0.93-5.63) 3.13 (0.98-9.99) 
Weight (kg) 
Female 68.1 (11.6)a 60.0 (19.1)a 0.94 (0.91-0.97) 0.95 (0.92-0.99) 
Male 75.2 (12.1)a 70.4 (15.8)a 0.94 (0.90-0.99) 0.93 (0.89-0.98) 
BMI(kg/m2) 
Female 26.5 (5.3)a 23.6 (6.0)a 0.85 (0.78-0.93) 0.90 (0.81-0.99) 
Male 25.4 (3.5)a 24.1 (5.2)a 0.82 (0.71-0.96) 0.79 (0.67-0.93) 
Comorbidities 
<4 138 (70.1) 59 (29.9) 1 1 
≥4 64 (57.1) 48 (42.9) 2.10 (1.20-3.68) 2.39 (1.26-4.54) 
Tumour site 
Superficial 87 (85.3) 15 (14.7) 1 Not applicable 
Intra-abdominal 115 (55.6) 92 (4.4) 3.87 (1.98-7.57)  
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Breast 67 (88.2) 9 (11.8) 1  
Colorectal 72 (61.5) 45 (38.5) 4.09 (1.74-9.59) 1 
Gastric and Oesophageal 10 (45.5) 12 (54.5) 9.60 (2.96-31.13) 2.33 (0.86-6.35) 
Gynaecological 15 (83.3) 3 (16.7) 1.18 (0.24-5.81) 0.32 (0.06-1.75) 
Pancreas and biliary tract 11 (37.9) 18 (62.1) 12.27 (3.42-44.03) 3.07 (1.12-8.40) 
Remaining 3 (33.3) 6 (66.7) 11.56 (2.02-66.21) 4.37 (0.41-47.06) 
Renal and bladder 12 (54.5) 10 (45.5) 7.09 (1.86-27.09) 1.65 (0.55-4.91) 
Soft tissue and skin 13 (81.3) 3 (18.8) 1.76 (0.27-11.45) Not performede 
Tumour stage 
Stage 1 or 2 120 (75.5) 39 (24.5) 1 1 
Stage 3 37 (56.9) 28 (43.1) 2.05 (1.07-3.92) 1.56 (0.73-3.37) 
Stage 4 25 (47.2) 28 (52.8) 2.58 (1.24-5.37) 1.76 (0.81-3.83) 
Values in parentheses in the second and third column are percentages unless indicated otherwise; values in 
parentheses in the final two columns are 95% CI; a values are median (i.q.r.); b adjusted for centre; c analysis 
of complete cohort; d sub-group analysis of patients with intra-abdominal tumours;  e only one patient with 
an intra-abdominal soft tissue tumour; kg = kilograms; BMI = Body Mass Index; Bold = statistically 
significant (≤ 0.05) 
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Table 4. Association between geriatric screening tools and impaired nutritional status 
Geriatric screening 
toola 
Normal 
nutritional 
status 
Impaired 
nutritional 
status 
Adjusted  OR  
model 1b, d 
Adjusted OR 
model 1c, d 
Adjusted OR 
model 2b 
Adjusted OR  
model 3c 
TUG 
≤20 s 177 (68.9) 80 (31.1) 1 1 1 1 
>20 s 25 (48.1) 27 (51.9) 1.99 (0.89-4.49) 1.42 (0.53-3.78) 1.12 (0.41-3.09) 1.14 (0.41-3.18) 
ADL 
0 168 (70.6) 70 (29.4) 1 1 1 1 
>0 35 (49.3) 36 (50.7) 2.16 (1.17-3.99) 2.41 (1.17-4.95) 1.66 (0.84-3.28) 2.23 (1.07-4.63) 
IADL 
8 137 (73.7) 49 (26.3) 1 1 1 1 
<8 66 (53.7) 57 (46.3) 2.20 (1.29-3.75) 3.11 (1.63-5.92) 1.67 (0.88-3.16) 2.82 (1.46-5.45) 
ECOG PS 
≤1 184 (71.6) 73 (28.4) 1 1 1 1 
>1 18 (34.6) 34 (65.4) 4.41 (2.16-8.97) 3.68 (1.60-8.48) 3.46 (1.56-7.67) 3.38 (1.44-7.95) 
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MMSE 
>26 135 (70.3) 57 (29.7) 1 1 1 1 
≤26 67 (57.3) 50 (42.7) 1.66 (0.98-2.80) 1.72 (0.93-3.16) 1.33 (0.72-2.45) 1.56 (0.84-2.91) 
GDS 
≤5 160 (71.4) 64 (28.6) 1 1 1 1 
>5 42 (49.4) 43 (50.6) 2.32 (1.25-4.30) 2.43 (1.16-5.10) 2.11 (1.05-4.26) 2.25 (1.06-4.77) 
BFI 
≤3 128 (69.2) 57 (30.8) 1 1 1 1 
>3 74 (59.7) 50 (40.3) 1.49 (0.87-2.56) 1.56 (0.83-2.93) 1.13 (0.61-2.12) 1.39 (0.73-2.66) 
ASA-score 
<3 124 (71.7) 49 (28.3) 1 1 1 1 
≥3 78 (57.4) 58 (42.6) 2.39 (1.39-4.12) 2.14 (1.13-4.04) 1.56 (0.81-2.99) 1.69 (0.86-3.35) 
Values in parentheses in the second and third column are percentages; values in parentheses in the other columns are 95% CI; a acronyms of the 
screening tools are spelled out in table 1; model 1 is adjusted for centre.; model 2 is adjusted for centre, age (continuous), comorbidities (<4 or 
≥4), tumour site (intra-abdominal  versus superficial) and tumour stage (1-4); model 3 is adjusted for centre and comorbidities (<4 or ≥4); b 
analysis of complete cohort; c sub-group analysis of patients with intra-abdominal tumours; d sensitivity analyses were performed for model 1 
with the complete cases of model 2 (minus 32 cases in which tumour stage was missing): n=277 for complete cohort and n=179 for sub-group 
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analysis: similar results were found (data not shown); Bold = statistically significant (≤ 0.05) 
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Table 5. Association between geriatric screening 
tools and major postoperative complications 
 
Geriatric screening toola 
 
Adjusted ORb 
NS 
Normal 1 
Impaired 3.3 (1.6-6.8) 
TUG 
≤20 s 1 
>20 s 3.1 (1.1-8.6) 
ASA-score 
<3 1 
≥3 2.8 (1.2-6.3) 
Values in parentheses are 95% CI; aacronyms of the 
screening tools are spelled out in table 1; badjusted 
for centre, gender and type of surgery 
